CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 691905-692157 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"The presence of antiphospholipid antibodies in the antiphospholipid syndrome is generally associated with prominent clinical manifestations of neurologic disorders that are predominantly related to focal central nervous system thrombo-occlusive events.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T47269","span":{"begin":0,"end":252},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T47269","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1405","span":{"begin":0,"end":252},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1405","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T202","span":{"begin":0,"end":252},"obj":"Sentence"}],"attributes":[{"subj":"T202","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T1292","span":{"begin":16,"end":43},"obj":"Phenotype"}],"attributes":[{"id":"A1292","pred":"hp_id","subj":"T1292","obj":"http://purl.obolibrary.org/obo/HP_0003613"},{"subj":"T1292","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2249","span":{"begin":204,"end":226},"obj":"Body_part"},{"id":"T2250","span":{"begin":212,"end":226},"obj":"Body_part"}],"attributes":[{"id":"A2249","pred":"uberon_id","subj":"T2249","obj":"http://purl.obolibrary.org/obo/UBERON_0001017"},{"id":"A2250","pred":"uberon_id","subj":"T2250","obj":"http://purl.obolibrary.org/obo/UBERON_0001016"},{"subj":"T2249","pred":"source","obj":"CORD-19-PD-UBERON"},{"subj":"T2250","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4225","span":{"begin":51,"end":76},"obj":"Disease"},{"id":"T4226","span":{"begin":143,"end":163},"obj":"Disease"},{"id":"T96674","span":{"begin":51,"end":76},"obj":"Disease"},{"id":"T12457","span":{"begin":143,"end":163},"obj":"Disease"}],"attributes":[{"id":"A4225","pred":"mondo_id","subj":"T4225","obj":"http://purl.obolibrary.org/obo/MONDO_0007140"},{"id":"A4226","pred":"mondo_id","subj":"T4226","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A44479","pred":"mondo_id","subj":"T96674","obj":"http://purl.obolibrary.org/obo/MONDO_0007140"},{"id":"A28592","pred":"mondo_id","subj":"T12457","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"subj":"T4225","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T4226","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T96674","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T12457","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec9398","default":true},{"id":"Epistemic_Statements","color":"#93b2ec"},{"id":"CORD-19_Custom_license_subset","color":"#ccec93"},{"id":"CORD-19-PD-HP","color":"#ec93e6"},{"id":"CORD-19-PD-UBERON","color":"#93ecd8"},{"id":"CORD-19-PD-MONDO","color":"#ecbe93"}]}]}}